Literature DB >> 16227530

Corticosteroids in herpes simplex virus encephalitis.

H Openshaw, E M Cantin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227530      PMCID: PMC1739394          DOI: 10.1136/jnnp.2005.071837

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  6 in total

Review 1.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

Review 3.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

4.  The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.

Authors:  Patric Lundberg; Chandran Ramakrishna; Jeffrey Brown; J Michael Tyszka; Mark Hamamura; David R Hinton; Susan Kovats; Orhan Nalcioglu; Kenneth Weinberg; Harry Openshaw; Edouard M Cantin
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

5.  Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.

Authors:  Chandran Ramakrishna; Alain N S Newo; Yueh-Wei Shen; Edouard Cantin
Journal:  PLoS Pathog       Date:  2011-06-02       Impact factor: 6.823

Review 6.  The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.

Authors:  Soren Gantt; William J Muller
Journal:  Clin Dev Immunol       Date:  2013-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.